Iranian scientists have developed a radiopharmaceutical for targeted treatment of neuroendocrine tumors, in another great step in the country’s efforts to use nuclear technology to promote medical science.
Rhenium-188 can be used in treating cancer developing neuroendocrine cells that have characteristics similar to nerve cells and hormone-producing cells.
Neuroendocrine tumors are rare and can develop anywhere in the body.
Most of the tumors arise in the lungs, appendix, small intestine, rectum, and pancreas.
Using the radiopharmaceutical, it is possible to diagnose and the treatment of neuroendocrine tumors and the resulting metastases will be provided to patients in the early stages of the disease.
A group of mourners took to Imam Reza’s shrine in the northeastern Iranian city of…
An Israeli military incursion into Gaza's southern city of Rafah could lead to a "bloodbath",…
The Ukrainian government is angering its citizens living abroad by its attempts to pressure them…
The level of water in the Zrebar Lake in western Iranian city of Marivan has…
The United Nations has issued a stark warning on the potential consequences of an Israeli…
Iranians in several cities bid farewell on Friday to the martyrs of the war with…